XML 14 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Restatement
3 Months Ended
Mar. 31, 2012
Restatement [Abstract]  
Restatement
Note 2.   Restatement

We are restating our previously reported financial information for the quarters ended March 31, 2012 and 2011 to change our accounting for interest rate swap agreements under ASC 815, "Derivatives and Hedging."
 
ASC 815 requires that all derivative instruments be recorded on the balance sheet as either an asset or a liability measured at its fair value, and that changes in the derivatives fair value be recognized in earnings unless specific hedge accounting criteria are met. We had applied the method of cash flow hedge accounting under ASC 815 to account for the interest rate swap agreements that allowed us to record changes in the instruments' fair value in other comprehensive income (the "cash flow" method). We recently concluded that the interest rate swap agreements did not qualify for the cash flow method because the documentation was not in place at the inception of the hedge as well as on an ongoing basis. This change reverses the fair value adjustments that were made in other comprehensive income to be recognized in earnings.

Although the swaps do not qualify for the cash flow method under ASC 815, there is no effect on cash flows from operating, investing, or financing activities for these changes. The change in the accounting treatment has not impacted the economics of the interest rate swap agreements.

The following table details the impact of the restatement on the Company's Statement of Operations and Balance Sheets for the periods ended March 31, 2012 and 2011.


(Dollars in thousands, except share data)
 
Three Months Ended March 31, 2012
  
Three Months Ended March 31, 2011
 
Statement of Operations Data:
 
As Reported
  
Restatement
  
Restated
  
As Reported
  
Restatement
  
Restated
 
Operating income
 $5,252  $-  $5,252  $4,666  $-  $4,666 
Other income and expense:
                        
Interest and other income
  20   -   20   10   -   10 
Interest expense
  (1,364)  (47)  (1,411)  (1,068)  339   (729)
Total other (expense)
  (1,344)  (47)  (1,391)  (1,058)  339   (719)
                          
Income before income taxes
  3,908   (47)  3,861   3,608   339   3,947 
Income tax provision
  1,586   (19)  1,567   1,466   135   1,601 
Net income
 $2,322  $(28) $2,294  $2,142  $204  $2,346 
Other comprehensive income, net of taxes
 $51  $28  $79  $269  $(204) $65 
Total comprehensive income
 $2,373  $-  $2,373  $2,411  $-  $2,411 
EPS
 $0.17  $-  $0.17  $0.16  $0.02  $0.18 
Diluted EPS
 $0.17  $-  $0.17  $0.16  $0.02  $0.18 
 
   
As of March 31, 2012
  
As of December 31, 2011
 
Balance Sheet Data:
 
As Reported
  
Restatement
  
Restated
  
As Reported
  
Restatement
  
Restated
 
Shareholders' equity:
                  
Common stock
 $1,349  $-  $1,349  $1,340  $-  $1,340 
Additional paid-in capital
  15,875   -   15,875   15,683   -   15,683 
Retained earnings
  32,241   (1,516)  30,725   31,797   (1,488)  30,309 
Accumulated other comprehensive income (loss)
  (5,572)  1,516   (4,056)  (5,623)  1,488   (4,135)
Total shareholders' equity
 $43,893  $-  $43,893  $43,197  $-  $43,197